Abstract Search

ea0070aep1092 | Hot topics (including COVID-19) | ECE2020

Cholesterol and Graves’ Orbitopathy (GO): ‘A new decision-making algorithm based on baseline low density lipoprotein cholesterol (LDLc) and early GO clinical response to parenteral corticosteroids’

Naselli Adriano , Moretti Diletta , Regalbuto Concetto , Luisa Arpi Maria , Logiudice Fabrizio , Frasca Francesco , Belfiore Antonino , Le Moli Rosario

Introduction: Parenteral corticosteroids (PC) are effective for the treatment of active moderate to severe (AMS) Graves’orbitopathy(GO). A correlation of GO activity with cholesterol has been described. No evidences are available about cholesterol levels and the clinical efficacy of PC in AMS-GO.Aim: Was to detect the predictive role of cholesterol on medium term clinical outcome of PC therapy in AMS-GO.Methods: We studied 87...

0 shares

Endocrine Abstracts

Cholesterol and Graves’ Orbitopathy (GO): ‘A new decision-making algorithm based on baseline low density lipoprotein cholesterol (LDLc) and early GO clinical response to parenteral corticosteroids’

BiosciAbstracts